Disc Medicine is a developer of medicines for hematologic diseases with three clinical-stage candidates. IRON's lead candidate, bitopertin, is currently in phase 2 trials targeting erythropoietic ...
Disc Medicine (IRON) has made great progress in advancing its lead candidate for its pipeline known as bitopertin for the treatment of patients with erythropoietic protoporphyria [EPP] and X-linked ...
The rare earths are a group of 17 metallic elements that find their way into products and industries from smartphones to fighter jets. Powerful, compact motors sporting magnets made from rare-earth ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback